Abstract
dc:descriptionIron is an essential element for the survival of all living organisms due to its involvement in basic biological procedures. However, free iron in excess is also highly toxic for the cell and therefore for the whole organism. Furthermore, mammals do not possess a special excretion pathway for its removal from the body. Therefore, the strict regulation of iron metabolism is necessary in order to avoid both its deficiency and overload. This means that cell types that are involved in iron absorption (enterocytes), utilization (erythrocytes), recycling (macrophages) and storage (hepatocytes) must work together so as to maintain its homeostasis. Recently it was found that this is achieved through the presence of a common hormonal regulator, hepcidin. Hepcidin is a small cationic peptide that was first discovered due to its antimicrobial properties. It is produced mainly by the liver in the form of an 84-aa propeptide (prohepcidin), which is enzymatically cleaved resulting to the active 25-aa form. Moreover, two more hepcidin isoforms of 20 and 22 amino acid residues have also been described. Τhe 20 and 25-aa peptides have been found both in serum and urine, while the 22 form was found only in urine. Hepcidin has a characteristic loop structure that is stabilized through the presence of 4 disulfide bonds between the molecule’s eight cysteine residues. Of highly importance is the fact that the last 5 amino acids at the N-terminal of hepcidin25 seem to be responsible for its iron-regulating activity. Hepcidin’s role in the human body is the inhibition of iron absorption from the intestine and iron recycling from macrophages. This function is achieved through its binding to its receptor, ferroportin (FPN1), promoting thus its internalisation and degradation in lysosomes. Ferroportin is expressed in enterocytes, macrophages and hepatocytes, where it is the cell’s sole iron exporter. Therefore, high levels of hepcidin result in the increase of ferroportin degradation and the sequestration of iron inside the cell. In contrast, low hepcidin levels result in the increased presence of ferroportin molecules at the cell surface and, therefore, in the induction of iron absorption and recycling. The regulation of hepcidin synthesis is controlled by many factors. Induction of hepcidin expression has been observed in inflammation, hypoxia and increased iron stores, while its inhibition has been reported in situation where iron stores are deplete and erythropoiesis is increased. The previous data suggest that hepcidin is the final common mediator in the regulation of iron homeostasis in response to both iron stores and erythropoiesis. Furthermore, studies have highlightened hepcidin’s crucial role in the pathogenesis of serious disorders of iron homeostasis in humans, like anaemia of chronic disease and hemochromatosis. Its quantification in biological fluids, as serum and urine, could provide further insight in its contribution to these diseases. During the past few years several such methods have been published. Most of them are based on the use of mass spectrometry (SELDITOF-MS ή LCMS/MS), but although results are hopeful, these techniques are characterised so far as semi-quantitative and demand the utilization of specialized equipment. There are two methods so far that are antibody-based· one is considered semi-quantitative and the other one detects prohepcidin, rendering its use controversial. The development of a facile ELISA assay would prove to be a potentially valuable tool for both research and diagnostic approaches. The first aim of this study was the production of human recombinant hepcidin isoforms of both 20- and 25-aa, with the use of a eukaryotic expression system, and the further evaluation of their activity...
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Koliaraki, Vasiliki
- Κολιαράκη, Βασιλική
Subjects
dc:subject × 19- Εψιδίνη
- Σίδηρος, Μεταβολισμός
- Φερροπορτίνη
- Μέθοδος ELISA
- Ποσοτικοποίηση στον ορό
- Αιμοχρωμάτωση, Νεανική
- Αναιμία χρόνιας νόσου
- Phage display
- Hepcidin
- Iron metabolism
- Ferroportin
- ELISA assay
- Serum quantification
- Juvenile hemachromatosis
- Anemia of chronic disease
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/24356